MIMEDX GROUP
MiMedx Group developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. They processes the human placental tissue utilizing its proprietary purion process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization.
MIMEDX GROUP
Industry:
Biotechnology Health Care Marketing Medical Medical Device Wellness
Founded:
2008-02-28
Address:
Marietta, Georgia, United States
Country:
United States
Website Url:
http://www.mimedx.com
Total Employee:
501+
Status:
Active
Contact:
+1 770 651 9100
Email Addresses:
[email protected]
Total Funding:
266.36 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
Rewalk Robotics
Rewalk Robotics provides a commercial walking assistance system for people with lower limb disabilities.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
PatientPoint
PatientPoint provide integrated patient engagement solutions surrounding key points of care to help healthcare professionals improve health.
Sinocelltech
Sinocelltech is a biotech company that develops and manufactures recombinant proteins, monoclonal antibodies, and vaccines.
TalexMedical
The proud producer of Infantear – a revolutionary Class I medical device for the treatment of external ear deformities in newborns.
Ombre
Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-01-10 | Stability Biologics | Stability Biologics acquired by MiMedx Group | 10 M USD |
| 2010-12-21 | MiMedx | MiMedx acquired by MiMedx Group | N/A |
Investors List
Medical Technology Enterprise Consortium
Medical Technology Enterprise Consortium investment in Grant - MiMedx Group
EW Healthcare Partners
EW Healthcare Partners investment in Post-IPO Equity - MiMedx Group
Hayfin Capital Management
Hayfin Capital Management investment in Post-IPO Debt - MiMedx Group
Official Site Inspections
http://www.mimedx.com Semrush global rank: 4.11 M Semrush visits lastest month: 2.94 K
- Host name: 104.20.26.52
- IP address: 104.20.26.52
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "MiMedx Group"
MiMedx - Wikipedia
MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008.Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin …See details»
MiMedx Group - Crunchbase Company Profile & Funding
MiMedx Group developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. They processes …See details»
MiMedx Group - Overview, News & Similar companies - ZoomInfo
Feb 1, 2024 MIMEDX to Host Second Quarter 2024 Operating and Financial Results Conference Call on July 31 MARIETTA, Ga., July 17, 2024 (GLOBE NEWSWIRE) -- MiMedx …See details»
MiMedx Group - Craft
Oct 29, 2024 MiMedx Group has 4 employees at their 1 location and $348.88 m in annual revenue in FY 2024. See insights on MiMedx Group including office locations, competitors, …See details»
MiMedx Group Inc Company Profile - Overview - GlobalData
MiMedx Group Inc (MiMedx) is a company that focuses on the development and distribution of placental biologics. The company provides innovative solutions for wound care, burn treatment …See details»
MIMEDX Group, Inc. | MiMedx Announces Board Approval of Long …
MARIETTA, Ga., April 11, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or "the Company"), an industry leader in advanced wound care and an emerging …See details»
Company Overview - MIMEDX
MIMEDX is a pioneer and leader in placental biologics focused on delivering innovative solutions to patients and the healthcare professionals who treat them. About Us With more than a decade of helping clinicians manage chronic and …See details»
MiMedx Group, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore MiMedx Group, Inc. with its drug pipeline, therapeutic area, technology platform, 37 clinical trials, 77 news, and 41 literature, Drug:dHACM (MiMedx), EpiCord ...See details»
MIMEDX Joins the RegenMed Hub – RegenMed Development …
MIMEDX is a placental biologics company and a pioneer in placental tissue engineering. The Company has distributed more than two million tissue allografts to date, primarily to address …See details»
Management Team and Board of Directors - MIMEDX
Mr. Hulse joined MIMEDX in December 2019, and brings to MIMEDX more than twenty years’ experience in large law firms and life sciences organizations, with significant legal, risk management, compliance and operational expertise. …See details»
MiMedx Group - Contacts, Employees, Board Members
MiMedx Group has 12 current employee profiles, including Chairman and CEO Parker H. Petit. Parker H. Petit Chairman and CEO Rebeccah J. C. Brown Vice President of Product …See details»
MiMedx Group - Overview, News & Similar companies - ZoomInfo
MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30 MARIETTA, Ga., Oct. 14, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: …See details»
MIMEDX Introduces E-Commerce and Account Management …
Mar 13, 2024 MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is …See details»
Contact Us - MIMEDX
MIMEDX | 1775 West Oak Commons Ct. NE | Marietta, GA 30062 | 888.543.1917 | 770.651.9100 | [email protected].See details»
Sustainability | MIMEDX
Our customer orientation core value guides that we engage with healthcare providers with the best interests of patients in mind. MIMEDX has established policies and procedures that all …See details»
Careers - MIMEDX
MIMEDX values the diversity of perspective, experience, and background within our company. We promote equal opportunity regardless of race, gender, nationality, ethnic origin, religion, age, …See details»
MIMEDX Group, Inc. - Facebook
MIMEDX has long been synonymous with excellence in wound care, setting standards for quality and reliability. With MIMEDX Connect, an innovative wound care management portal, this …See details»
Q1 2025 MiMedx Group Inc Earnings Call - Yahoo Finance Canada
13 hours ago We have several initiatives underway aimed to institutionalize customer-centered behavior throughout the organization. We continue to experience excellent adoption of …See details»
A Peek at MiMedx Group's Future Earnings - Nasdaq
2 days ago Tracking MiMedx Group's Stock Performance. Shares of MiMedx Group were trading at $6.83 as of April 28. Over the last 52-week period, shares are down 3.89%.See details»
MIMEDX Announces Fourth Quarter and Full Year 2024 Operating …
Feb 26, 2025 Net Sales Grew 7% Year-Over-Year for the Fourth Quarter and 9% for the Full Year. Fourth Quarter GAAP Net Income and Earnings Per Share were $7 million and $0.05, …See details»